Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 10 (October)

1. Asenapine effects in animal models of psychosis and cognitive function.
   Psychopharmacology (Berl), 206(4): 699-714. [Abstract] [Full-text]
2. Reduced limbic connections may contraindicate subgenual cingulate deep brain stimulation for intractable depression.
   J Neurosurg, 111(4): 780-4. [Abstract] [Full-text]
3. ANTAGONISTIC COEVOLUTION OF TWO IMPRINTED LOCI WITH PLEIOTROPIC EFFECTS.
   Evolution. [Abstract] [Full-text]
4. Executive functioning in twins with bipolar I disorder and healthy co-twins.
   Arch Clin Neuropsychol, 24(6): 599-606. [Abstract] [Full-text]
5. Bipolar disorder and mechanisms of action of mood stabilizers.
   Brain Res Rev, 61(2): 185-209. [Abstract] [Full-text]
6. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions.
   Eur Neuropsychopharmacol, 19(11): 791-5. [Abstract] [Full-text]
7. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis.
   Psychol Med, 39(11): 1783-97. [Abstract] [Full-text]
8. The role of asymmetric frontal cortical activity in emotion-related phenomena: A review and update.
   Biol Psychol. [Abstract] [Full-text]
9. Characteristics and concordance of autism spectrum disorders among 277 twin pairs.
   Arch Pediatr Adolesc Med, 163(10): 907-14. [Abstract] [Full-text]
10. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.
    Arch Gen Psychiatry, 66(10): 1072-80. [Abstract] [Full-text]
11. Lithium response across generations.
    Acta Psychiatr Scand, 120(5): 378-85. [Abstract] [Full-text]
12. Facial emotion recognition in patients with bipolar I and bipolar II disorder.
    Br J Clin Psychol, 48: 363-75. [Abstract] [Full-text]
13. The genetics of bipolar disorder.
    Neuroscience, 164(1): 331-43. [Abstract] [Full-text]
14. Measuring hypomania in the postpartum: a comparison of the Highs Scale and the Altman Mania Rating Scale.
    Arch Womens Ment Health, 12(5): 323-7. [Abstract] [Full-text]
15. Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.
    Neuroscience, 164(1): 88-107. [Abstract] [Full-text]
16. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis.
    J Psychiatr Res, 43(15): 1200-4. [Abstract] [Full-text]
17. Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three?
    J Psychiatr Pract, 15(5): 415-22. [Abstract] [Full-text]
18. Treatment of bipolar disorders and metabolic syndrome: implications for primary care.
    Postgrad Med, 121(5): 140-4. [Abstract] [Full-text]
19. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
    Postgrad Med, 121(5): 20-30. [Abstract] [Full-text]
20. Treatment options for children and adolescents with bipolar disorder.
    J Clin Psychiatry, 70(9): e34. [Abstract] [Full-text]
21. Diagnosis and impact of bipolar depression.
    J Clin Psychiatry, 70(9): e32. [Abstract] [Full-text]
22. TAAR 6 and HSP-70 variations associated with bipolar disorder.
    Neurosci Lett, 465(3): 257-61. [Abstract] [Full-text]
23. A model of the economic impact of a bipolar disorder screening program in primary care.
    J Clin Psychiatry, 70(9): 1230-6. [Abstract] [Full-text]
24. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    J Clin Psychiatry, 70(9): 1273-80. [Abstract] [Full-text]
25. Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy.
    J Sex Med, 6(10): 2901-9. [Abstract] [Full-text]
26. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.
    Neuroscientist, 15(5): 525-39. [Abstract] [Full-text]
27. Health services utilization by school going Omani adolescents and youths with DSM IV mental disorders and barriers to service use.
    Int J Ment Health Syst, 3(1): 22. [Abstract] [Full-text]
28. Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice.
    PLoS One, 4(10): e7461. [Abstract] [Full-text]
29. Violent behavior in acute psychiatric inpatient facilities: a national survey in Italy.
    J Nerv Ment Dis, 197(10): 772-82. [Abstract] [Full-text]
30. Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis.
    J Psychopharmacol. [Abstract] [Full-text]
31. Prevalence and age-of-onset distributions of DSM IV mental disorders and their severity among school going Omani adolescents and youths: WMH-CIDI findings.
    Child Adolesc Psychiatry Ment Health, 3(1): 29. [Abstract] [Full-text]
32. Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort.
    Psychopathology, 42(6): 380-6. [Abstract] [Full-text]
33. Co-occurring conditions and health-related quality of life in patients with bipolar disorder.
    Psychosom Med, 71(8): 894-900. [Abstract] [Full-text]
34. Altered risk-aversion and risk-seeking behavior in bipolar disorder.
    Biol Psychiatry, 66(9): 840-6. [Abstract] [Full-text]
35. Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder.
    Neurosci Lett, 466(1): 27-9. [Abstract] [Full-text]
36. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome.
    J Affect Disord, 119(1): 177-80. [Abstract] [Full-text]
37. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
    J Affect Disord, 119(1): 22-7. [Abstract] [Full-text]
38. Predominant polarity and temperament in bipolar and unipolar affective disorders.
    J Affect Disord, 119(1): 28-33. [Abstract] [Full-text]
39. Demonstration of disturbed activity of external globus pallidus projecting neurons in depressed patients by the AgNOR staining method.
    J Affect Disord, 119(1): 149-55. [Abstract] [Full-text]
40. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study.
    J Affect Disord, 119(1): 16-21. [Abstract] [Full-text]
41. Lower CSF MHPG predicts short-term risk for suicide attempt.
    Int J Neuropsychopharmacol, 12(10): 1327-35. [Abstract] [Full-text]
42. Mood-related sleep problems in children and adolescents.
    Child Adolesc Psychiatr Clin N Am, 18(4): 893-916. [Abstract] [Full-text]
43. Epigenetic mediation of environmental influences in major psychotic disorders.
    Schizophr Bull, 35(6): 1045-56. [Abstract] [Full-text]
44. Does a psychoeducational approach reach targeted patients with bipolar disorder?
    J Affect Disord, 119(1): 190-3. [Abstract] [Full-text]
45. Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients.
    J Affect Disord, 119(1): 205-9. [Abstract] [Full-text]
46. Actigraphic recording of manic symptoms induced by methylphenidate.
    Case Report Med, 2009: 286430. [Abstract] [Full-text]
47. Cigarette smoking is associated with suicidality in bipolar disorder.
    Bipolar Disord, 11(7): 766-71. [Abstract] [Full-text]
48. Performance of the mood disorders questionnaire in a psychiatric outpatient setting.
    Bipolar Disord, 11(7): 759-65. [Abstract] [Full-text]
49. Sexually dimorphic features of vermis morphology in bipolar disorder.
    Bipolar Disord, 11(7): 753-8. [Abstract] [Full-text]
50. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Bipolar Disord, 11(7): 726-34. [Abstract] [Full-text]
51. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Bipolar Disord, 11(7): 711-25. [Abstract] [Full-text]
52. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
    Bipolar Disord, 11(7): 701-10. [Abstract] [Full-text]
53. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Bipolar Disord, 11(7): 687-700. [Abstract] [Full-text]
54. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
    Bipolar Disord, 11(7): 673-86. [Abstract] [Full-text]
55. The longitudinal course of cognition in older adults with bipolar disorder.
    Bipolar Disord, 11(7): 744-52. [Abstract] [Full-text]
56. Cognitive features in euthymic bipolar patients in old age.
    Bipolar Disord, 11(7): 735-43. [Abstract] [Full-text]
57. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex.
    Neuroimage, 49(1): 767-71. [Abstract] [Full-text]
58. Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress.
    Proc Natl Acad Sci U S A, 106(42): 17957-62. [Abstract] [Full-text]
59. Epidemiology and management of anxiety in patients with bipolar disorder.
    CNS Drugs, 23(11): 953-64. [Abstract] [Full-text]
60. Profiles of disability among adults with bipolar spectrum disorders.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
61. Impulsivity, personality and bipolar disorder.
    Eur Psychiatry, 24(7): 464-9. [Abstract] [Full-text]
62. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.
    Mol Psychiatry, 14(11): 1051-66. [Abstract] [Full-text]
63. Neural correlates of the females' susceptibility to negative emotions: an insight into gender-related prevalence of affective disturbances.
    Hum Brain Mapp, 30(11): 3676-86. [Abstract] [Full-text]
64. Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features.
    Psychosomatics, 50(5): 543-7. [Abstract] [Full-text]
65. The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis.
    J Clin Psychiatry. [Abstract] [Full-text]
66. Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
    Pharmacotherapy, 29(11): 1386-91. [Abstract] [Full-text]
67. Psychiatric and psychotherapeutic literacy: attitudes to, and knowledge of, psychotherapy.
    Int J Soc Psychiatry, 55(6): 525-37. [Abstract] [Full-text]
68. Microduplications of 16p11.2 are associated with schizophrenia.
    Nat Genet, 41(11): 1223-7. [Abstract] [Full-text]
69. Safety and efficacy of quetiapine in bipolar depression.
    Ann Pharmacother, 43(11): 1848-56. [Abstract] [Full-text]
70. Bipolar disorder patient care opportunities: let's answer the call.
    Ann Pharmacother, 43(11): 1890-2. [Abstract] [Full-text]
71. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
    Alcohol Clin Exp Res, 33(11): 1863-9. [Abstract] [Full-text]
72. Lithium: a key to the genetics of bipolar disorder.
    Genome Med, 1(8): 79. [Abstract] [Full-text]
73. Asenapine.
    Nat Rev Drug Discov, 8(11): 843-4. [Abstract] [Full-text]
74. Genetics of attention-deficit hyperactivity disorder (ADHD).
    Neuropharmacology, 57(7): 590-600. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.